Literature DB >> 25784520

Usefulness of preoperative atrial fibrillation to predict outcome and left ventricular dysfunction after valve repair for mitral valve prolapse.

Catherine Szymanski1, Julien Magne2, Alexandre Fournier1, Dan Rusinaru1, Gilles Touati3, Christophe Tribouilloy4.   

Abstract

The aim of the study was to assess the impact of atrial fibrillation (AF) on outcome in patients who underwent mitral valve repair (MVRp) for mitral valve prolapse (MVP). Four hundred and forty-three consecutive patients underwent MVRp for organic mitral regurgitation due to MVP. Echocardiography was performed preoperatively and after surgery. Postoperative left ventricular dysfunction (LVD) was defined as left ventricular ejection fraction (LVEF) <50%. Before surgery, 187 patients (42%) had preoperative AF. After surgery, LVEF significantly decreased from 67 ± 9% to 56 ± 10% (p <0.0001). Compared with patients in sinus rhythm (SR), those in AF were significantly older (p <0.0001), had more severe symptoms (p = 0.004), had lower LVEF (p = 0.002), and higher EuroSCORE (p = 0.05). Compared with patients in SR, patients with AF had significantly lower 10-year survival (64 ± 4% vs 83 ± 3%, p = 0.001). On multivariate analysis, preoperative AF was identified as an independent predictor of overall mortality (hazard ratio 1.67; 95% confidence interval 1.15 to 2.42; p = 0.007). At 10 years, patients with paroxysmal AF had lower survival and higher heart failure rate than patients in SR (78 ± 3% vs 66 ± 6%) but had a better outcome compared with those with permanent AF (66 ± 6% vs 53 ± 6%, p = 0.022). Patients with AF had a significantly higher rate of postoperative LVD (23.3% vs 13.4%, p = 0.007). In conclusion, preoperative AF is a predictor of long-term mortality and postoperative LVD after MVRp for MVP. To improve postoperative outcome, surgery in these patients should be performed before onset of AF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25784520     DOI: 10.1016/j.amjcard.2015.02.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Risk factors of chronic left ventricular dysfunction after cardiac valve surgery.

Authors:  Xingli Fan; Yangfeng Tang; Guanxin Zhang; Jiajun Zhang; Qing Xue; Boyao Zhang; Zhiyun Xu; Lin Han
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 2.895

Review 2.  Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward.

Authors:  Maciej Kubala; Christian de Chillou; Yohann Bohbot; Patrizio Lancellotti; Maurice Enriquez-Sarano; Christophe Tribouilloy
Journal:  Front Cardiovasc Med       Date:  2022-02-15

3.  Stage-based approach to predict left ventricular reverse remodeling after mitral repair.

Authors:  Makoto Hibino; Nitish K Dhingra; Vincent Chan; C David Mazer; Hwee Teoh; Adrian Quan; Raj Verma; Howard Leong-Poi; Gianluigi Bisleri; Kim A Connelly; Subodh Verma
Journal:  Clin Cardiol       Date:  2022-06-24       Impact factor: 3.287

4.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.